8-KThe WireStrategic
Material Agreement · Agreement Terminated
Filed May 8, 2026 · 1mo ago · Accession 0001140361-26-019761
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- May 8, 2026
- Report date
- May 7, 2026
- Document
- ny20072667x2_8k.htm
- Size
- 161 KB